News & Events

Press Releases

Presentations

AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders – March 9, 2024

A phase 1b Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of ALX-001, an mGluR5 Silent Allosteric Modulator, in Healthy Older Adults

Presented by Tim Siegert, PhD

16th Clinical Trials on Alzheimer’s Disease – October 27, 2023

A phase 1a single ascending dose study of the safety, tolerability, and brain receptor occupancy of BMS-984923 in healthy older adults
Presented by Adam P. Mecca MD, PhD